Facts & Figures

Selected key financial figures

In EUR mio. 2021 2020 2019
Revenues 11.63 8.12 6.14
Operating result (EBIT) -4.14 -5.82 -6.21
Loss for the year -5.89 -6.01 -7.22
Cash and cash equivalents per 31.12. 5.80 9.21 12.02
Balance sheet total per 31.12. 21.34 23.50 19.50
Net cash flow -3.40 -2.81 10.30
R&D expenses 7.50 5.94 4.78

Marinomed Corporate Presentation & Factsheet

Stephanie Kniep, Dipl.-Ök.
Head of Investor Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com